Loss of Bcl-2 expression in Barrett’s dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation

Authors:

Abstract
Summary. Esophageal adenocarcinoma arising on a background of Barrett’s esophagus is increasing in incidence. A molecular understanding of both the progression